# Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea

> **NCT06977347** · NA · NOT_YET_RECRUITING · sponsor: **CHOSEOK YOON** · enrollment: 100 (estimated)

## Conditions studied

- Severe Community-acquired Pneumonia (sCAP)

## Interventions

- **DRUG:** Piperacillin/Tazobactam
- **DRUG:** Piperacillin/tazobactam + Levofloxacin

## Key facts

- **NCT ID:** NCT06977347
- **Lead sponsor:** CHOSEOK YOON
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-15
- **Primary completion:** 2026-12-31
- **Final completion:** 2027-02-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06977347

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06977347, "Appropriateness of Antibiotic Combination Therapy for Severe Community-acquired Pneumonia in South Korea". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06977347. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*